Drug Discovery

RFD4-Proteina is integrated into cloud computing workflows including Google Cloud and Amazon Bio Discovery to democratize access to advanced biotechnology tools. This strategic integration marks a defining moment in 2026, as the field of biochemistry matures from a science of discovery into a

The massive training dataset for Carbon-X spanned 302 billion tokens, incorporating genetic material from mammals, plants, fungi, and microorganisms to ensure broad biological utility. Developed as a collaborative effort between the Zhongguancun Academy and European research institutes, this

The global biotechnology market currently stands at a transformative crossroad as the latest findings from BioNTech’s clinical pipeline indicate that the roadmap for oncology is significantly more nuanced than the rapid success of COVID-19 vaccines once suggested. This announcement, while initially

The intersection of reproductive health and oncology reached a significant turning point this year as clinical evidence began to suggest that medications used to calm the brain’s thermostat could also serve as a potent defense against tumor growth. For several years, the medical community has

The $15 billion expansion of the Roche-Hansoh partnership signals a massive shift toward multi-program antibody-drug conjugate portfolios rather than traditional single-asset licensing deals. This momentous agreement, finalized in late 2026, represents a fundamental restructuring of how global

Regulatory hurdles and the complexity of characterizing nanoparticle behavior in humans have slowed the progress of bone-targeted nanomedicines. Despite these significant challenges, osteosarcoma remains a primary concern in pediatric oncology due to its high rate of metastasis and the persistent